Our Stocks to Watch today include Magnum D'Or Resources Inc. (OTCBB: MDOR), San West Inc. (OTCBB: SNWT), Force Energy Corp. (OTCBB: FORC), Jaguar Mining Enterprises Inc. (OTC: JAGR), Muscle Flex Inc. (OTC: MFLI), Green Energy Live Inc. (OTCBB: GELV), Zevotek Inc. (OTC: ZVTK), Sinoenergy Corp. (Nasdaq: SNEN), MDRNA Inc. (Nasdaq: MRNA), XTend Medical Corp. (OTC: XMDC), Astrotech Corp. (Nasdaq: ASTC) and Invicta Group Inc. (OTC: IVIT).
Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.
MAGNUM D'OR RESOURCES (OTCBB: MDOR)
Detailed Quote: http://www.otcpicks.com/quotes/MDOR.php
Company Profile: http://www.otcpicks.com/magnum-resources/magnum-resources.htm
Magnum d'Or Resources, Inc. focuses in operating in recycling and waste management sectors. It intends to develop facilities that produce rubber powders, thermoplastics, and thermoplastics elastomers. Magnum holds licensing rights to various patents that would allow rubber to be devulcanized, specialty blend EPDM powders, and EPDM compounds. The company was founded in 1999 and is based in
MDOR News:
October 12 - Magnum/SRI Revolutionary Custom Compound in Light Truck Tires Ready for Impending RRI On-Road Trials
Magnum D'Or Resources, Inc. (OTCBB: MDOR), a next generation rubber recycling Solutions Company, announces On-Road Trials with the World Renowned "Malaysia Rubber Research Institute" facility in Sungai Buloh www.lgm.gov.my.
Having successfully produced light truck tires using Magnum/SRI Revolutionary custom compound as a 20% component in the production compound, the resultant manufactured tires were submitted to the Rubber Research Institute's (RRI), Malaysian Rubber Board, Tire Lab for testing along with the original tires. The preliminary tests including abrasion resistance were passed with flying colours achieving results within the pre-specified parameters and near identical to the original (OEM) tires. Magnum/SRI is thrilled to announce once again that this is a major Breakthrough and a World's First for the Global Rubber Market. Furthermore the tires were then further tested for in-lab continuous destructive testing which is still ongoing.
The tires are also being tested for performance in actual Road Performance performed by the Rubber Research Institute (RRI) Tire Lab where our Light Truck (3Metric Tonne cap) is installed with both original control tires along with the Magnum/SRI tires. Measurements are taken by the RRI test lab personnel and then the Truck is run on normal roads with a standard load and brought back for further measurements following a fixed protocol schedule based on distance travelled on the certified odometer. The measurements including abrasion / wear resistance among other parameters will be carefully tabulated throughout the life of the tires (30,000km), the tires changed out and the process repeated several times. These trials commence as soon as the registration and inspection of the truck is completed which is expected later this week.
Generally this on the road test is usually carried out on tires that have been retreaded and rarely carried out on original OEM tires as they have established performance and their compound specs do not vary a great deal. In this case the Magnum/SRI Revolutionary Custom Compound is being evaluated in premium compound applications against premium original manufactured light truck tires (unheard of until now). Several firsts for the worldwide rubber industry right off the bat and Magnum/SRI is happy to state, "they have achieved the unachievable."
Once the destructive tests have been completed and the on-road trials carried out by the RRI Test Lab has run for some time, we will be starting independent evaluation of Magnum/SRI custom compounds by the RRI in several value added applications. The independent evaluation by the RRI will provide substantial credibility in the industry and will be further supported by carrying out similar independent trials at the Tun Abdul Razak Research Centre (Tarrc) in the United Kingdom while they also run their special Trailer trials on retreaded heavy trailer tires, operated on roads under controlled and a wide variety of wet and dry conditions.
As we develop our range of Magnum/SRI Revolutionary custom compounds we will be able to improve their performance in each of the major application categories towards establishing its position as an accepted industrial raw material.
SAN WEST INCORPORATED (OTCBB: SNWT)
Detailed Quote: http://www.otcpicks.com/quotes/SNWT.php
Company Profile: http://www.otcpicks.com/san-west-inc.htm
San West designs, manufacturers, sells and repairs off-road buggies, and additionally provides aftermarket performance products and accessories for off-road buggies; products are sold via three divisions: at retail store locations; via the online store and; through its growing dealer network. Buggy repair services are sold and fulfilled at the Santee California retail location.
SNWT News:
October 9 - San West, Inc. Enters Into 3.2 Million Dollar Partnership With Second Largest Online Dealer in
Partnership Expected to Put Company Into "Top-Tier of Internet Commerce" Within Sector
San West, Inc. (OTCBB: SNWT), a Company that designs, manufactures, sells and repairs off-road buggies, announced that it has entered into a partnership with one of the largest online retailers in the off-road recreation sports market, CountyImports.com.
Having served over 25,000 customers since 2004, CountyImports.com is the second largest online dealer in the
Frank Drechsler, President and CEO of San West, Inc. said today of the announcement, "This partnership is going to put Buggy World into the top tier of Internet commerce in our sector. We have the ability to execute seamless order fulfillment and CountyImports.com is one of the biggest players in online sales so this is a perfect fit. This partnership also offers us the opportunity to market our aftermarket parts and upgrades, which do exceptionally well in the e-commerce arena, to a much wider market. Our goal is to be a one-stop-shop for consumers and this partnership will achieve that."
Jesse Gonzalez, founder of CountyImports.com, had this to say regarding the alliance with Buggy World, "After years of working in the same industry, we have come to know Buggy World as one of those companies that you want to do business with. CountyImports.com was built from a similar foundation of ethical standards and has an excellent business reputation. Not only will this partnership build an all-star cast with over 150 years of combined experience, but this synergistic move will create a powerhouse of sales, customer service and brand recognition. Needless to say, we have very high expectations for this
Under the new partnership, Buggy World will act as dealer, order fulfillment and customer service for CountyImports.com. All transactions, income and expenses generated from the website will be booked through Buggy World. San West, Inc. estimates that the addition of CountyImports.com gross sales will increase corporate revenue by more than 3 million dollars in 2010.
San West Inc. Provides Historical Index of Corporate Announcements, Comments on Recent Developments
San West, Inc. (OTCBB: SNWT), a Company that designs, manufacturers, sells and repairs off-road buggies, announced the availability of corporate press releases disseminated prior to its recent name and ticker change from Human Biosystems (OTCBB: HBSY).
It has come to the attention of San West management that interested parties attempting to conduct an online search for information on the company under its new ticker symbol "SNWT" have at times been unable to access past corporate announcements highlighting some of our most significant achievements to date.
Therefore, the company has deemed it helpful to provide a comprehensive list of San West Inc. press releases issued prior to 9/28/09 as well as a link to each announcement online at our news-wire service www.marketwire.com.
Frank Drechsler, CEO of San West Inc., states: "I'm pleased to announce that the public will now be able to access a historical index of San West Inc.'s media communications. Now, the public can more easily see (1) the milestones that our growing Company has achieved; and (2) the positive direction that we are moving."
Mr. Drechsler added: "In addition, I feel that it is prudent at this time to provide an update on our 8/20/09 announcement regarding the opening of a new Buggy World Location in
FORCE ENERGY CORPORATION (OTCBB: FORC)
Detailed Quote: http://www.otcpicks.com/quotes/FORC.php
Company Profile: http://www.otcpicks.com/Newsletter/FORC_eProfile_100709.htm
Force Energy Corp. is an Oil & Gas Exploration and Development Company based in
FORC News:
October 9 - Force Energy Corp. Issues Clarification and Retraction of Prior Press Release Announcing $5 Million Equity Financing
Force Energy Corp. (OTCBB: FORC) (Frankfurt: FC2) (hereafter "Force", "the Company"), issued a press release on October 7, 2009 regarding the Company's entry into a financing agreement pursuant to which the Company may receive up to $5 Million of equity financing. The Company is issuing a release today to clarify that the agreement is between the Company and Villa Atmu S.A. not Bank SCS Alliance as referred to in the October 7, 2009 release.
The financing agreement is equity based and market condition dependent. The agreement may be receded by either party with 30 days notice. Funds from the agreement are intended to be used to advance drilling activities on the Diamond Springs Prospect as well as for general working capital and investment purposes. Force Energy has secured only traditional equity financing.
October 7 - Force Energy Corp. Announces $5 Million Equity Financing
Force Energy Corp. (OTCBB: FORC) (Frankfurt: FC2) (hereafter "Force", "the Company"), announced that the company has entered into a financing agreement with Banque SCS Alliance, whereby the Swiss based banking group will invest up to $5 million into Force Energy Corp.
The financing agreement is equity based and market condition dependent. The agreement may be receded by either party with 30 days notice. Funds will be used to advance drilling activities on the Diamond Springs Prospect as well as for general working capital and investment purposes. Force Energy has secured only traditional equity financing.
"We are pleased to have Bank SCS Alliance in our corner." Said Rahim Rayani, President & CEO of Force Energy Corp. "This financing agreement will allow the Company to execute on our plans to explore and develop the Diamond Springs Prospect."
The securities offered have not been registered under the Securities Act of 1933 and may not be offered or sold in the
JAGUAR MINING ENTERPRISES INCORPORATED (OTC: JAGR)
"Up 33.33% in morning trading"
Detailed Quote: www.otcpicks.com/quotes/JAGR.php
Company Profile: http://www.otcpicks.com/jaguar-mining/jaguar-mining.htm
Jaguar Mining Enterprises, Inc. is an independent mining company engaged in the acquisition, development, and exploitation of iron ore primarily mined in
JAGR News:
October 7 - Jaguar Mining Enterprises Schedules Meeting on Cascaronal Mine
Jaguar Mining Enterprises, Inc. (OTC: JAGR), an independent mining company engaged in the acquisition, development, and exploitation of iron ore primarily mined in Mexico, announced that it has scheduled a meeting with all mining project personnel in anticipation of the receipt of the permit for the Cascaronal Mine.
"A number of topics will be discussed including extraction schedule, local labor force requirements, as well as the confirmation of existing agreements related to the project," said Dale Williams, President of Jaguar Mining Enterprises, Inc. "Addressing these items and reviewing potential issues now will help to ensure a smooth transition when this project shifts into the production stage."
MUSCLE FLEX INCORPORATED (OTC: MFLI)
"Up 9.09% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MFLI.php
Company Profile: http://www.otcpicks.com/muscle-flex-inc.htm
Muscle Flex Inc. brings new products to market using direct response TV infomercials specializing in the health, fitness, wellness and hygiene sectors. As well, Muscle Flex Inc. develops and creates general television content for network and cable television distribution. Muscle Flex's corporate strategy is to develop new and innovative products for sale and distribution via its proprietary direct response marketing system and the creation of television media and shows for general network and cable broadcast.
MFLI News:
October 8 - Muscle Flex Developing a Strong Product Portfolio in the 'Water' Category to Include Filtration, Bottled Water and Health Infused Water
Muscle Flex Inc. (OTC: MFLI) (www.MuscleFlexInc.com) announced that it is developing a strong portfolio of "Water" related products to market using its direct response, online ecommerce and traditional retail methods. Muscle Flex® regards "Water" as potentially the most important ingredient in maintaining a healthy lifestyle and it is estimated that as much as 75% of Americans do not drink enough good clean water. Water consumption is one of Danny Alex's, the CEO and Founder of Muscle Flex Inc., 30 fitness rules to living a better and healthier lifestyle. Muscle Flex is developing a several water related products and will be included as one of Muscle Flex's main product categories.
Muscle Flex is currently finalizing an at-home water filtration product it expects to retail from between $19.95 - $29.95 that it intends to market via a 2 minute short form commercial. Muscle Flex is developing a comprehensive list of "Water" related products from easy at-home and on-the-go filtration products to bottled water and water that is infused with additional nutrients and enhanced benefits.
The benefits of drinking ample amounts of water are numerous:
* Dehydration can slow down one's metabolism as much as 3%
* One glass of water can shut down midnight hunger angst.
* Lack of water is considered the primary reason for daytime fatigue.
* Research indicates that 8-10 glasses of water a day could significantly ease back and joint pain for up to 80% of sufferers.
* A mere 2% drop in body water can trigger fuzzy short-term memory, trouble with basic math, and difficulty focusing on the computer screen or on a printed page.
* Drinking ample amounts of water daily has been found to decreases the
risk a number of negative human conditions and diseases.
"Water products are a major focus for Muscle Flex Inc.," commented Danny Alex. "If people drank 1 or 2 glasses of water when they felt sluggish, tired or fatigued, within minutes they would feel revived and come alive. Water is something that everyone MUST drink and everyone understands the importance of it. Muscle Flex will be a one-stop provider of real-life 'Water' solutions for people ... solutions that are innovative and that can easily be applied to anyone's lifestyle. Becoming and staying healthy is all about simple one-step at a time lifestyle changes that take hold and stick as permanent lifestyle changes. As with the majority of Muscle Flex products, the Muscle Flex lifetime guarantee will apply to our water related products. It shows our commitment to quality as well as building the brand name, Muscle Flex, that people trust and hold in high regard. Unequivocal consumer trust in Muscle Flex and in all Muscle Flex brands is critically important as an over-all corporate mission."
GREEN ENERGY LIVE INCORPORATED (OTCBB: GELV)
"Up 7.69% in morning trading"
Detailed Quote: www.otcpicks.com/quotes/GELV.php
Company Profile: http://www.otcpicks.com/green-energy-live.htm
GELV is a fully reporting, publicly-listed engineering and technology company focused on developing and commercializing renewable energy gasification systems that convert biomass wastes, currently being dumped in land-fills, into fuel and other valuable co-products. What is unique about GELV is that its technology can rapidly and economically be deployed to the waste site rather than vice versa. Thus, a customer's specific needs are addressed through a complete equipment package with the smallest ecological footprint.
GELV News:
October 7 - Green Energy Live Patent for Liquefaction Technology Accepted
Green Energy Live (OTCBB: GELV) announced that the United States Patent Office accepted the company's patent for liquefaction technology. The official patent number is US 7,559,537. Karen Clark, CEO of Green Energy, commented, "The acceptance of our patent is another positive development for our company and shareholders, as our competitive position in the market place is further strengthened."
"One of the major problems with existing systems used to create alternative bio-fuels are their large size, not to mention the tremendous cost of hauling the feedstock to the plant," said Ms. Clark. "By integrating multiple components of the process, our technology eliminates the need for the expensive, extensive and potentially explosive connecting pipelines and turbine pumps that are commonly used now. Furthermore, because we can scale down the liquefaction process, it may now be brought directly to the source of feedstock — the farm, thus further reducing the ecological footprint of the system."
ZEVOTEK INCORPORATED (OTC: ZVTK)
"Up 58.62% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/ZVTK.php
Zevotek, Inc. plans to market and sell independently a range of distinct and independent lines of home care and household products. In May 2007, the company entered into a license agreement to sell an energy saving compact fluorescent light bulb named the Ionic Bulb. The company plans to market the Ionic Bulb through TV infomercials, catalogs, magazines and major
ZVTK News:
October 12 - Zevotek Orders Ionic Bulbs for
Zevotek, Inc. (OTC: ZVTK) (Frankfurt: T5V1), a designer, developer and worldwide direct marketer and distributor of innovative personal and home care items, announced that it placed a factory order to start producing Ionic Bulbs for U.S. customers. Zevotek is buying Ionic Bulbs to fill anticipated customer orders designed to come from TV and Internet viewers in homes across the
The Ionic Bulb is designed for consumer use by combining the performance features of ionic air cleaning technology with those of a 10,000 hour reduced energy use compact fluorescent light bulb (CFL). According to ENERGY STAR®, a joint program of the U.S. Environmental Protection Agency and the U.S. Department of Energy, a qualified CFL will save about $30 over its lifetime and pay for itself in about 6 months. It uses 75 percent less energy and lasts about 10 times longer than an incandescent bulb. ENERGY STAR® said earlier this year that using less energy helps reduce air pollution and greenhouse gas emissions from power plants.
Commenting on the announcement, Zevotek's CEO, Adam Engel, said, "I believe Zevotek's Ionic Bulb is the right product at the right time. Ionic Bulbs deliver the money saving value that
SINOENERGY CORPORATION (NASDAQ: SNEN)
"Up 41.41% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/SNEN.php
Sinoenergy is a developer and operator of retail CNG stations as well as a manufacturer of CNG transport truck trailers, CNG station equipment, and natural gas fuel conversion kits for automobiles, in
SNEN News:
October 12 - Sinoenergy Corporation Signs Merger Agreement With Skywide Capital Management Limited
Stockholders to Receive $1.90 per share
Sinoenergy Corporation (Nasdaq: SNEN), developer and operator of retail compressed natural gas (CNG) filling stations in the People's Republic of China and a manufacturer of CNG transport truck trailer, CNG filling station equipment and CNG fuel conversion kits for automobiles, announced that, on October 12, 2009, the Company entered into an agreement with Skywide Capital Management Limited, pursuant to which the Company will be merged with and into Skywide. Upon the effectiveness of the merger, each issued and outstanding share of the Company's common stock, other than shares owned by Skywide, will automatically be converted into the right to receive $1.90 per share.
Skywide, which is owned by the Company's chairman, Mr. Tianzhou Deng, and its president, Mr. Bo Huang, is the Company's largest shareholder, owning approximately 39.06% of the Company's outstanding common stock.
The merger agreement provides that the consummation of the merger is subject to the approval of the holders of a majority of the Company's outstanding common stock and customary closing conditions. As a result of the merger, the Company will cease to exist as a separate corporation, and its common stock will no longer be publicly traded.
The merger was approved by the board of directors, upon the recommendation of a special committee of the board which was comprised solely of independent directors.
Brean Murray, Carret & Co. served as financial advisor to the Company in this transaction and rendered a fairness opinion to the special committee with respect to the transaction. Arent Fox LLP acted as legal advisor to the special committee of the Company's board. Sichenzia Ross Friedman Ference LLP acted as legal advisor to the Company. Mintz & Fraade P.C. acted as legal advisor to Skywide.
Additional Information and Where to Find It
In connection with the proposed merger, the Company will prepare a proxy statement for the shareholders of the Company to be filed with the SEC. Before making any voting decision, the Company's shareholders are urged to read the proxy statement regarding the merger carefully in its entirety when it becomes available because it will contain important information about the proposed transaction. The Company's shareholders and other interested parties will be able to obtain, without charge, a copy of the proxy statement (when available) and other relevant documents filed with the SEC from the SEC's website at http://www.sec.gov . The Company's shareholders and other interested parties will also be able to obtain, without charge, a copy of the proxy statement and other relevant documents (when available) by directing a request by mail or telephone to Sinoenergy Corporation, 1603-1604, Tower B Fortune Centre Ao City, Beiyuan Road, Chaoyang District, Beijing, People's Republic of China 100107, Attention: Investor Relations; and +86-10-84928149, or to Georgeson Inc., the Company's proxy solicitor, toll-free in the United States, 877-278-4751; Banks and Brokers should call 212-440-9800.
Participants in the Solicitation
The Company and its directors and officers may be deemed to be participants in the solicitation of proxies from the Company's shareholders with respect to the merger. Information about the interests of the Company's directors and officers in the transaction, which may differ from other shareholders generally, will be set forth in the proxy statement and other relevant documents regarding the merger when they are filed with the SEC.
MDRNA INCORPORATED (NASDAQ: MRNA)
"Up 33.87% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MRNA.php
MDRNA is a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). Our goal is to improve human health through the development of RNAi-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Over the past decade, we have developed substantial capabilities in molecular biology, cellular biology, lipid chemistry, peptide chemistry, pharmacology and bioinformatics, which we are applying to a wide range of RNAi technologies and delivery approaches. These capabilities plus the in-licensing of key RNAi-related intellectual property have rapidly enabled us to become a leading RNAi-based therapeutics company with a pre-clinical pipeline in key therapeutic areas including oncology, metabolic disorders and inflammation. Through our capabilities, expertise and know-how, we are incorporating multiple RNAi technologies as well as peptide- and lipid-based delivery approaches into a single integrated drug discovery platform that will be the engine for our clinical pipeline as well as a versatile platform for establishing broad therapeutic partnerships with biotechnology and pharmaceutical companies. We are also investing in new technologies that we expect to lead to safer and more effective RNAi-based therapeutics while aggressively building upon our broad and extensive intellectual property estate. By combining broad expertise in siRNA science with proven delivery platforms and a strong IP position, MDRNA is well positioned as a leading RNAi-based drug discovery and development company.
MRNA News:
October 12 - MDRNA Reports UsiRNA Reduces Tumor Growth In Vivo
Demonstrates RNAi-Mediated Knockdown of Previously "Non-Druggable" Targets in Liver and Bladder Cancers
MDRNA, Inc. (Nasdaq: MRNA), a leading RNAi-based drug discovery and development company, presented new in vivo data demonstrating continued progress in the advancement of the Company's oncology program. J. Michael French, President and CEO, reported that MDRNA's UsiRNAs, delivered by the Company's DiLA2 platform, down-regulated a previously "non-druggable" target with subsequent reductions in tumor growth in models of liver and bladder cancer via both systemic and local delivery.
In a presentation to BioPartnering Europe in London today, Mr. French said that MDRNA has demonstrated successful delivery of a UsiRNA targeting survivin, a protein involved in mitotic progression and inhibition of apoptosis, via intravenous administration using its DiLA2 liposome formulation in two liver cancer models. Knockdown ( > 60%) of survivin mRNA in a rodent orthotopic model was noted as early as 24 hours after a second (of six) dose and this was associated with an approximate 65% decrease in tumor weight at study termination; this decrease was comparable to tumor weight reduction with Avastin� (bevacizumab)-treated mice as a positive control. A similar level of survivin mRNA knockdown was noted in subcutaneously implanted liver tumors following intravenous administration of the UsiRNA/DiLA2 liposomes.
Data from an orthotopic bladder cancer model were also presented, in which localized application (intravesical dosing) of the survivin UsiRNA to a bladder tumor was performed using a DiLA2 liposome formulation. Again, the UsiRNA was highly active in providing gene silencing, demonstrating > 90% inhibition of survivin mRNA which was dose-dependent and sustained over at least a three week period. At study termination there was also a dose-dependent decrease in bioluminescence of up to approximately 90% in UsiRNA-treated mice which is a clear indication of reduced tumor growth.
Mr. French said, "We have always maintained that our RNAi discovery engine can generate novel compounds with broad therapeutic applicability. These data are a powerful indicator of the value and strength of that drug discovery platform and represents a significant step in the advancement of our product pipeline. Moreover, we now have evidence illustrating the potential role of RNAi-based therapeutics in down-regulating typically 'non-druggable' targets."
The presentation given by Mr. French is posted on the Company website (www.mdrnainc.com).
ABOUT USIRNAS
A UsiRNA is a duplex siRNA containing at least one Unlocked Nucleobase Analog (UNA). In a UsiRNA, UNAs are non-nucleotide monomers and synthesized much like RNA in the construction of a double-stranded oligonucelotide for use as an RNAi-based therapeutic. In the case of the UsiRNA, UNA is substituted for specific nucleotides in both the guide and passenger strands. UsiRNAs are fully recognized by the cellular RNAi machinery, as demonstrated by their potent activity. MDRNA has also shown that substitution of UNA for specific RNA increases stability to nucleases, substantially reduces cytokine induction, and reduces passenger and guide strand-mediated offtarget effects. The high potency, and improved drug-like properties, associated with UsiRNAs provide the potential to greatly enhance RNAi-based therapeutics.
ABOUT THE DILA2 DELIVERY PLATFORM
The DiLA2 Delivery Platform is MDRNA's proprietary platform for creating novel liposomal delivery systems based on di-alkylated amino acids (DiLA2). The DiLA2 Platform enables MDRNA to tailor the charge, linker length, and acyl chain characteristics to improve delivery of the liposomes to target tissue of interest. In vivo studies have demonstrated effective delivery in models of metabolic disease, cancer, and other diseases. DiLA2-based liposomes are well tolerated for repeat dose, and systemic and local administration. MDRNA is also utilizing condensing peptides to form peptide-siRNA nanoparticles to further increase the delivery efficiency of its DiLA2 delivery systems. In addition, the platform is designed to permit attachment of peptides and other targeting molecules for delivery to a variety of tissues, and thus provide for a diverse therapeutic portfolio.
XTEND MEDICAL CORPORATION (OTC: XMDC)
"Up 26.67% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/XMDC.php
XTend Medical is a company that specializes in the manufacturing and distribution of the latest in telemedicine and telehealth solutions for the healthcare industry. Their dedication to insuring the products and services offered to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. Their continued efforts in identifying global companies with true product potential in the healthcare industry puts them in an advantageous position to capitalize on a global basis.
XMDC News:
October 6 - Letter to Shareholders of XTend Medical From the CEO Regarding the Upcoming Merger With
XTend Medical Corp. (OTC: XMDC), a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following letter from the CEO, Mr. Paul D. Lisenby, regarding the upcoming merger with BioHarp, Korea and other corporate progress.
"To all XTend shareholders, I want to bring everyone up to date on the upcoming merger with
The work done by our management team with the principles at
There was a press release in February 2008, issued by Hathaway Corporation, announcing a joint venture with UNI Bio-Tech for the BioHarp device. As I was with the company at that time acting as the interim CEO, I knew the value of BioHarp. However, since the Board of Directors of Hathaway decided to change their business model to become FutureWorld Energy and focus their efforts on the renewable energy sector, the joint venture never took place and the deal was cancelled in April of 2008. My work with Hathaway has since stopped and for the last 18 months my sole responsibility has been to ensure XTend Medical brings value to our shareholders and puts itself in a position to capitalize on opportunities to grow the company. Through this merger, the company will become a global leader in the healthcare sector and it will be up to all of us here at XTend Medical and
Since the announcement of this merger, we have been working hard with Pink Sheets to become fully compliant with their reporting requirements. We should have this accomplished by week's end and hopefully have the Stop Sign removed from our company's profile. Our goal is to move up to a greater exchange due to the potential sales that we anticipate the BioHarp will be doing globally very soon. We are working with our accountant and legal teams to ensure that we have everything in order so the migration to a higher exchange can be accomplished at the proper time. Any changes we've recently made to the corporate structure are to effectuate this merger and any and all shares issued for this merger are subject to Rule 144 Restrictions. As we update Pink Sheets, the information will be there for all shareholders to review. We are in the process of updating our site and will share additional information about our progress in future press releases. In closing, I would like to thank all of our loyal shareholders for their dedication and for potential future shareholders; this company will be strong and have a very bright future for many years to come."
ASTROTECH CORPORATION (NASDAQ: ASTC)
"Up 31.43% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/ASTC.php
Astrotech is one of the first space commerce companies and remains a strong entrepreneurial leader in the aerospace industry. The Company serves our government and commercial satellite and spacecraft customers with our pre-launch services from our Astrotech Space Operations (ASO) subsidiary and incubates space technology businesses having formed three companies; the 1st Detect Corporation is developing what we believe is a breakthrough mini-mass spectrometer; Astrogenetix, Inc. expects to produce biotech products in space and has recently developed a vaccine candidate for Salmonella; and AirWard Corporation is drawing on Astrotech’s space heritage of sending cargo to space by selling hazardous material containers for the airline industry.
ASTC News:
September 28 - Astrotech Reports Financial Results for Fourth Quarter and Fiscal Year 2009 and Announces Exploration of Strategic Alternatives
Astrotech Corporation (Nasdaq: ASTC) announced financial results for its fourth quarter and fiscal year ended June 30, 2009.
“This reporting period commemorates our return to profitable earnings and the completion of the turnaround for Astrotech that started in January 2007,” said Thomas B. Pickens III, Chairman and CEO. “The Company is now on a firm foundation and I feel very confident about the future of Astrotech and its expected earnings going forward.”
Fourth Quarter Results
The Company posted a fourth quarter fiscal year 2009 net income of $2.6 million, or $0.15 per diluted share on revenue of $10.4 million compared with a fourth quarter fiscal year 2008 net loss of $1.5 million, or $(0.11) per diluted share on revenue of $6.1 million.
Fiscal Year Results
Astrotech’s net income for the fiscal year ended June 30, 2009 was $4.7 million, or $0.28 per diluted share on revenue of $32.0 million compared to a net loss of $36.0 million, or $(4.26) per diluted share on revenue of $25.5 million for the prior fiscal year. These results represent a 25.2% increase in revenue over fiscal year 2008. Additionally, this marks the first time since 2005 that the Company has reported net income for the fiscal year.
Liquidity
As of June 30, 2009, we had cash on hand of $4.7 million and our working capital was approximately $8.4 million. The Company maintains a $6.0 million financing facility with Green Bank, N.A., consisting of a $4.0 million term loan and a $2.0 million revolving credit facility. On June 30, 2009, $3.6 million of the term loan, which expires in February 2011, was outstanding. During third quarter fiscal year 2009, the Company renewed the one-year revolving credit facility through February 2010 on terms substantially similar to the previous facility. At June 30, 2009, the Company had no outstanding liability under the revolving credit facility.
Update of Ongoing Operations
Astrotech’s growth strategy is to build on its industry-leading ground support operations and offer a more comprehensive set of services to government and commercial satellite customers through its wholly owned and largest subsidiary, Astrotech Space Operations (“ASO”). Specifically, the Company has developed and has begun to offer an End-to-End
The Company has a backlog of $25.4 million as of June 30, 2009. The majority of this backlog is for ASO pre-launch satellite processing services, which include hardware launch preparation; advance planning; use of unique satellite preparation facilities; and, spacecraft checkout, encapsulation, fueling, transport, and remote control through launch.
Strategic Financial and Business Alternatives
Astrotech also announced today that its Board of Directors has engaged investment banking firm Lazard Ltd. to advise the Company in exploring strategic financial and business alternatives to enhance shareholder value. Lazard Middle Market is the midcap focused financial advisory business of Lazard.
The range of alternatives which may be considered could include strategic acquisitions, a sale of some or all of the company’s assets or a variety of other possible transactions. There can be no assurance regarding the timing of or whether the Company will elect to pursue any of the strategic alternatives it may consider, or that any such alternatives will result in changes to the Company’s plans or will be consummated.
INVICTA GROUP INCORPORATED (OTC: IVIT)
"Up 25.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/IVIT.php
Invicta Group, Inc. is a full service multimedia management and marketing company. Invicta utilizes a number of websites, a large database, event productions and promotions, and its experienced team to help clients manage, maintain and improve their overall businesses. Current projects include:
IVIT News:
October 7 - The Invicta Group Signs a Joint Venture Agreement With Water Tower SurgiCenter, Chicagoland's
The Water Tower SurgiCenter Recently Remodeled Its Operating Rooms to Become One the Country's Most State-of-the-Art Facilities
Invicta Group Inc. (OTC: IVIT) announced that the Company has entered into a Joint Venture Agreement with the prestigious Water Tower SurgiCenter located at 845 N. Michigan Ave in Chicago. The main purpose of this new partnership is for the Invicta Group to help an established and successful location with management, marketing and new doctor recruitment.
The Water Tower Surgery Center is Chicagoland's premier same-day surgery center specializing in same day surgery for over 20 years. Over 50 staff physicians are board certified and performs their surgeries in our completely remodeled state-of-the-art facility. The center is located on
Projected Revenues for 2010 are approximately $ 10,000,000 with Net Profits in the range of $ 2,000,000 to $ 2,500,000.
Dr. Paul Madison is the medical director for the Water Tower SurgiCenter. Dr. Madison attended
Dr. Madison said, "I have been very impressed with everything the Invicta Group has to offer and I am looking forward to expanding and improving what I have started."
Invicta Group's CEO Paul Sorkin said, "Dr. Madison and all the center's staff physicians are very talented elite doctors. We are looking forward to getting more doctors involved to offer additional services and focus on exceeding the patients' overall expectations. This is an incredible opportunity for our shareholders and we are looking forward to the endless possibilities with our new business partner."
OTCPicks.com is located at
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org.
Disclosure: OTCPicks has been compensated ten thousand dollars from a non-controlling third party (GREEN TECH INTERNATIONAL ADVISORS) for MDOR advertising and promotional services. OTCPicks.com has been compensated three thousand five hundred dollars by a third party (Green Horseshoe) for SNWT advertising and promotional services. OTCPicks.com has been compensated four thousand dollars by a third party for FORC advertising and promotional services. OTCPicks.com has been compensated two hundred thousand free trading shares by a third party (Microcap Management) for JAGR advertising and promotional services. OTCPicks.com has been compensated three thousand five hundred dollars from Dana Alex for MFLI advertising and promotional services. OTCPicks.com has been compensated four thousand dollars by a third party for a one-week GELV advertising and promotional program. OTCPicks.com has been compensated two thousand five hundred dollars by a third party (Green Horseshoe) for ZVTK advertising and promotional services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. OTCPicks.com is a website partially owned by BlueWave Advisors, LLC, a financial public relations firm. BlueWave Advisors, LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
